BiondVax Pharma (BVXV) Presents Preliminary Phase II Data from BVX-006 Trial of M-001

June 29, 2015 3:53 PM

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) today announced positive preliminary results from its BVX-006 Phase II clinical trial of M-001, BiondVax's ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found